Regulatory mechanisms of T cell autoreactivity to MHC class II molecules were studied in transgenic (Tg) mice with auto-I-A k -reactive TCR αβ transgenes (designated as MS Tg mice). Our previous study revealed that the T cell tolerance established in autoreactive MS Tg mice was not due to either clonal deletion in the thymus, anergy or an active suppression in the periphery. We proposed a novel form of self tolerance termed 'clonal insufficiency', where autoreactive T cells were conditionally rendered unresponsiveness to self antigen in vivo, although retaining full potential reactivity in in vitro conditions. Here, we investigated the role of co-stimulatory molecules for the induction of self tolerance with 'clonal insufficiency'. MS Tg mice were mated with CD80 (B7-1) Tg mice in which B cells exclusively and constitutively expressed CD80 molecules. Both MS
Introduction
Most of the autoreactive T cells are thought to be deleted in the thymus by TCR-specific negative selection (1) (2) (3) (4) (5) (6) . However, the negative selection is not always complete, and some autoreactive T cells enter and survive in the peripheral lymphoid tissues (7) (8) (9) (10) . Such T cells are known to be either anergic or suppressed (11) (12) (13) (14) (15) . Consistent with the existence of autoreactive T cells in the physiological conditions, the syngeneic mixed lymphocyte reaction is easily detected in vitro (16, 17) . There exists a large number of autoreactive T cell clones which respond to autologous antigen-presenting cells (APC) in the absence of exogenous antigens (18, 19) . To investigate the molecular mechanism that inhibits the selfreactivity of physiologically existing autoreactive T cells, we have established a transgenic (Tg) mouse with TCR α and β
Correspondence to: T. Nakayama Transmitting editor: M. Taniguchi Received 18 September 1997, accepted 21 October 1997 genes from a well characterized I-A k -reactive CD4 ϩ T cell clone MS202 which was derived from a normal C3H (H-2 k ) spleen (12) . Unique features in the T cell development and T cell functions in the MS Tg mice have been reported (10) . It was found that MS Tg T cells appeared to be positively selected in the H-2 k thymus where the ligand (I-A k ) to Tg TCR was expressed. This was in contrast to the general notion that Tg T cells are deleted in the thymus by negative selection observed in other antigen-specific, MHC-restricted αβTCR Tg mice (4) (5) (6) . Secondly, MS Tg mice with a H-2 k background had a large number of Tg CD4 T cells in the periphery without any manifestation of autoimmune phenomena. The MS Tg T cells were, however, not anergic as evidenced by their abilities to respond to autologous APC to proliferate and to produce IL in vitro. There was no evidence for the presence of suppressor T cells that inhibited the autoreactivity of Tg T cells. Thus, the self tolerance observed in MS Tg mice is induced and maintained by a mechanism different from previously known forms of central and peripheral tolerance (20) . We have proposed a term 'clonal insufficiency' for the observed self tolerance where autoreactive T cells are conditionally unable to respond to self antigens, although retaining the full potential reactivity (10) . Here, we have extended our studies using the MS Tg model system and investigated the role of co-stimulatory molecules for establishing and maintaining the self tolerance with 'clonal insufficiency'. It has been well documented that at least two signals are required for T cell activation (14) . One is mediated by antigen recognition by the TCR (first signal), and the other is mediated by interactions between the co-receptors on T cells and costimulatory molecules on APC (second signal) (21) . Among the co-receptors that deliver a second signal into T cells during antigen recognition, B7 [B7-1 (CD80) and B7-2 (CD86)] and CD28 appear to be critical (reviewed in 22) . Antigenic stimulation through TCR without co-receptor signals generally leads to a failure of T cell activation and, in some cases, to an anergic state (23) (24) (25) . Indeed, recent studies using Tg mice with ectopic expression of antigens on a certain tissue cell type having no appropriate co-stimulatory activity revealed the induction of T cell unresponsiveness either by deletion (26) (27) (28) , anergy (29) or receptor down-modulation (9). Ohashi et al. and Oldstone et al. reported independently that autoreactive T cells were circulating without any autoimmune responses when the cells expressing autoantigens could not provide appropriate co-stimulatory signals to the autoreactive T cells (30, 31) . From this perspective, the initiation of some autoreactive responses may largely depend on the expression of appropriate co-stimulatory molecules on the cells that express autoantigens.
There are two ligands for CD28, i.e. CD80 (B7-1) and CD86 (B7-2). Although both CD80 and CD86 appear to be involved in the second signals, there are several distinct features (22) . The expression of CD80 is low on resting B cells and upregulated during B cell activation by lipopolysaccharide, concanavalin A or cAMP, while a significant level of CD86 expression is detected on resting B cells (32) (33) (34) (35) . Recent studies in the NOD mouse system suggested that CD80 can regulate immune responses, especially following initial antigen exposure (22, 36) .
Recently, the regulation of CD80 and CD86 expression on B cells has been extensively studied. Stimulations through MHC class II molecules on B cells induce CD80 expression and the cytoplasmic portion of the class II appears to be important (37, 38) . Both CD80 and CD86 expression on B cells are induced by CD40-CD40L interaction (39, 40) . On the other hand, the engagement of FcR down-regulates both CD80 and CD86 on monocytes (41) . The expression of CD80 and CD86 is also regulated by several kinds of cytokines. IL-4 induces CD86 on B cells very effectively, whereas CD80 is up-regulated to a lesser extent (42, 43) . IFN-γ and IL-4 induce CD86 on B cells and peritoneal macrophages (35, 41, 43) . Among cytokines that regulate CD80 or CD86 expression, only IL-10 is known to block CD80 and CD86 upregulation during B cell activation (44, 45) .
In this study, we investigated the role of co-stimulatory molecules in the regulation of T cell autoreactivity to MHC class II by using an autoreactive TCR Tg model system. We crossed our autoreactive αβTCR MS Tg mice with CD80 Tg mice whose B cells expressed CD80 molecules constitutively. The results obtained from the MSϫCD80 double-Tg mice indicated that the self tolerance established in the MS Tg mouse involved down-regulation of CD80 molecules on B cells resulting in a failure of sufficient T-B interactions. In addition, the involvement of IL-10 for the down-regulation of CD80 expression on B cells in MS Tg mice was suggested.
Methods

Animals
C3H/HeJ mice were purchased from Clea (Tokyo, Japan). The characters of an autoreactive TCRαβ Tg (MS Tg) mice were described previously (10) and were back-crossed to C3H mice for Ͼ10 generations. Anti-ovalbumin TCRαβ transgenic (DO10 Tg) mice (46) were kindly provided by Dr Dennis Loh (Nippon Roche Research Center, Kanagawa, Japan). A CD80 Tg mouse strain with a FVB (H-2 k ) background in which CD80 Tg was expressed on B cells was generated and kindly provided by Dr Abul K. Abbas (47) . All mice used in this study were maintained under specific pathogen-free conditions.
Reagents
The reagents used in this study were as follows: FITCconjugated anti-TCRV β 4 (KT4-FITC) (48), anti-CD80 (RM80-FITC) (49), anti-CD86 (PO.3-FITC) (49) , anti-TCRα of 2B4 T cell hybridoma mAb-FITC (A2B4-FITC, as a negative control) (50), anti-B220-biotin (RA3-6B2-biotin) (51) and anti-CD8-Cy5 (53-6.72-Cy5) (52) were prepared in our laboratory. Anti-CD80 and anti-CD86 mAb were kindly provided by Dr K. Okumura (Juntendo University, Tokyo, Japan). Phycoerythrin (PE)-conjugated anti-CD4 (GK1.5-PE) was purchased from Becton Dickinson Immunocytometry Systems (Mountain View, CA). Anti-CD4-FITC (GK1.5-FITC), anti-I-A k -FITC (11-5.2-FITC) and anti-CD69-FITC (H1.2F3-FITC) were purchased from PharMingen (La Jolla, CA). For blocking experiments, anti-FcRγI mAb (2.4G2) (53), anti-CD80 (RM80) and anti-CD86 (PO.3) were used as culture supernatants. PE-conjugated streptavidin (PE-avidin) were purchased from Leinco (Ballwin, MO).
Immunofluorescent staining and flow cytometry (FCM) analysis
Freshly prepared thymocytes and splenocytes or in vitro cultured spleen cells were suspended in PBS supplemented with 2% FCS and 0.1% sodium azide. In general, 1ϫ10 6 cells were incubated on ice for 30 min with appropriate staining reagents as described (54) . For direct stainings, cells were first incubated with 2.4G2 to prevent non-specific binding of mAb via FcR interactions. In multicolor FCM analysis, electronic compensation was done by using cell mixtures of positive and negative cell populations in each fluorescence emission. FCM analysis was performed on FACS Vantage or FACSort (Becton Dickinson Immunocytometry Systems), and fluorescence data were collected as a list mode on 40,000 or 100,000 viable cells as determined by light scatter parameters and propidium iodide (PI) exclusion. CELLQuest software programs (Becton Dickinson Immunocytometry Systems) were used for collecting and analyzing data.
Cell culture
Whole spleen cells from MS Tg mice were cultured for 3 days at 37°C in RPMI 1640 supplemented with 10% FCS, 1 mM Lglutamine and antibiotics (penicillin and streptomycin). Where indicated, 25% culture supernatant of anti-CD80 or anti-CD86 mAb, or mouse recombinant IL-10 (500 ng/ml; PharMingen) was added (44) . Cells were cultured at a concentration of 1ϫ10 7 cells/ml in 24-well tissue culture plates (Costar 3424; Costar, Cambridge, MA). Where indicated, 2.5ϫ10 6 or 5ϫ10 6 cells were cultured. After 3 days cultivation, cells were harvested and subjected to FCM analysis.
Measurement of IL-10 concentration by ELISA
Serum levels of IL-10 concentration was measured by using a mouse IL-10 ELISA kit (Endogen, Cambridge, MA). In this detection system, the lower limit for detection was 12 pg/ ml. For measurement of IL-10 concentration in the culture supernatant, splenic T cells (3ϫ10 6 /ml) from MS Tg mice were stimulated with immobilized anti-TCR mAb (H57-597; 100 µg/ml) or anti-CD3 mAb (145-2C11; 100 µg/ml) in 24well tissue culture plates (Costar 3424) and after 24, 48 or 72 h the culture supernatant was subjected to ELISA with the mouse IL-10 ELISA kit (Endogen).
In vitro T h 1/T h 2 cell induction and intracellular stainings of IL-4 and IFN-γ
CD4 ϩ T cells with naive phenotype (CD44 -) were prepared as follows: MS Tg splenocytes were incubated with culture supernatants of both anti-CD8 (53-6.72) and anti-CD44 (IM7) mAb followed by guinea pig complement (1:10). The treated cells were washed and then incubated on plastic dishes (Iwaki 3020-100) coated with goat anti-mouse IgG (which cross-react with rat IgG, including 53-6.72). The non-adherent cells were used as naive CD44 -CD4 ϩ T cell population. APC were prepared from C3H (H-2 k ) splenocytes by cytotoxic killing with anti-Thy-1 mAb and guinea pig complement (1:10), and were irradiated (3000 rad) before adding the stimulation culture. CD44 -CD4 ϩ T cells (1ϫ10 6 ) from MS Tg mice were co-cultured with 1ϫ10 6 APC for 5 days in 1 ml culture in 24well plates (Costar 3424).
For intracellular stainings of IL-4 and IFN-γ, the cultured T cells were re-stimulated with immobilized anti-TCR mAb (H57-597; 100 µg/ml) for 6 h in the presence of 4 µM monensin (Sigma, St Louis, MO) which inhibited the secretion of newly produced cytokines. Then, the cells were fixed with 4 % paraformaldehyde for 10 min at room temperature and permeabilized in a permeabilizing solution (50 mM NaCl, 5 mM EDTA, 0.02% NaN 3 , pH 7.5) containing 0.5% Triton X for 10 min on ice. After blocking with 3% BSA in PBS for 15 min, cells were incubated on ice for 45 min with anti-IFN-γ-FITC (XMG1.2-FITC) and anti-IL-4-PE (11B11-PE) which were purchased from PharMingen.
Results
Normal numbers of autoreactive TCR Tg T cells exist in the spleen of H-2 k MS Tg mice without activation
A goal of this study was to determine the molecular mechanism responsible for establishing and maintaining self tolerance in autoreactive TCR Tg mice (designated as MS Tg mice). TCR α and β chain genes from a CD4-dependent auto-I-A k -reactive T cell clone MS202 (12) were used for the MS Tg mice (10) . Yields of thymocytes and splenocytes, and the numbers of CD4 T cells of MS Tg mice with H-2 k background were similar to those of Tglittermates (10) ( Fig. 1A) . Most of the CD4 T cells express Tg TCRβ chain, TCRV β 4 and probably Tg TCRα, because these characteristics were also observed in H-2 k MS Tg mice with SCID background (10) . The expression of CD69 and CD25 on the splenic CD4 T cells of MS Tg mice was examined and no difference was detected ( Fig. 1 B) . These results indicated that the auto-I-A k -reactive Tg T cells were not activated in the spleen of H-2 k C3H mice.
In vitro activation of MS Tg T cells detected by cell surface expression of CD69 and CD25
Although MS Tg T cells were quiescent in vivo, they expressed full reactivity to self I-A k in 37°C suspension cultures in vitro resulting in proliferation and a production of large amounts of IL (10) . Here, the activation status of cultured MS Tg CD4 T cells was determined by cell surface expression of activation marker antigens, CD69 and CD25. Whole spleen cells from MS Tg mice, normal C3H mice and control TCRαβ Tg (DO10 Tg) mice were cultured for 3 days at 4 or 37°C in vitro in the absence of exogenous antigens, and were stained with anti-CD4 and either anti-CD69 or anti-CD25. Staining profiles of CD69 and CD25 on electronically gated CD4 T cells are demonstrated in Fig. 2 (A). The majority of cultured CD4 T cells of MS Tg mice expressed CD69 and CD25 after simple suspension cultures at 37°C. Most of the CD69 ϩ cells expressed CD25 (data not shown). In contrast, only marginal increases in numbers of CD69 ϩ or CD25 ϩ were detected in either normal C3H or control DO10 TCR Tg T cells. No increase in the expression of CD69 on B cells was detected in either culture tested (data not shown). In addition, the induction of CD69 and CD25 on MS Tg T cells was significantly inhibited when anti-I-A k mAb was present (data not shown). These results indicated that the majority of MS Tg T cells were activated in the in vitro suspension cultures by interacting I-A k -bearing cells, and expressed CD69 and CD25.
The co-stimulatory signals mediated by CD28 were thought to be required for a full activation of T cells during antigen recognition (22) . A considerable amount of CD28 is expressed on splenic T cells in vivo in either control C3H or MS Tg mice (10) . We wished to examine the expression of its ligands CD80 and CD86 on B cells in the above MS Tg suspension cultures. The cultured spleen cells from MS Tg mice were stained with anti-B220 and either anti-CD80, anti-CD86 or anti-I-A k mAb (Fig. 2B ). Consistent with previous reports (reviewed in 22), little CD80 expression was found to be detected on B cells which were freshly prepared (data not shown) or in vitro cultured at 4°C (dotted lines). However, substantial increases of CD80 expression on B cells were detected when MS Tg spleen cells were cultured at 37°C for 3 days (solid lines). In contrast, a substantial amount of CD86 was already expressed on B cells before culture and marginal increases were detected after 37°C cultivation. A considerable amount of class II (I-A) molecules was expressed on B cells in vivo and up-regulated after 3 day suspension cultures in vitro.
Involvement of CD80 and CD86 molecules in MS Tg T cell activation induced by in vitro suspension cultures
Next, the involvement of CD80 and CD86 molecules in the activation of MS Tg T cells in vitro was directly examined by the addition of anti-CD80 mAb and CD86 mAb to the cultures (Fig. 3 ). Spleen cells from MS Tg, normal C3H and control TCR Tg (DO10 Tg) mice were simply cultured at 37°C for 3 days in vitro in the presence or absence of anti-CD80 mAb or CD86 mAb. The cells were harvested and stained with anti-CD4 and either anti-CD69 or anti-CD25. CD69 and CD25 staining profiles of electronically gated CD4 T cells were demonstrated in Fig. 3 . The induction of cell surface expression of CD69 and CD25 observed in MS Tg cultures was significantly inhibited when anti-CD80 mAb or anti-CD86 mAb was added in the culture. These results indicated that both CD80 and CD86 molecules were involved in the activation of MS Tg T cells in vitro.
Normal cellularity in the spleen of CD80 single-Tg mice
The results thus far obtained suggested that the expression of CD80, CD86 and I-A k was required for the activation of MS Tg T cells in vitro. Among them, CD80 was not detectably expressed on freshly prepared B cells in MS Tg mice, where no activation of Tg T cells was observed. However, the expression of CD80 was induced by the in vitro suspension cultures at 37°C where MS Tg T cells were activated. Consequently, we assumed that the MS Tg T cells could be activated in vivo when CD80 molecules were expressed constitutively on B cells in the H-2 k spleen. We reasoned, therefore, that MS Tg mice were mated with CD80 Tg mice where all B220 ϩ B cells constitutively expressed CD80 molecules (47) .
First, freshly prepared spleen cells from non-Tg littermates and CD80 single-Tg mice were stained with anti-CD4, anti-CD8 and either anti-CD80, anti-CD69 or anti-CD25. These mice have the FVB (H-2 k ) background. Figure 4 (A) demonstrates representative CD4/CD8 staining profiles of spleen cells. Yield is also shown as a boxed number. As previously described, no significant difference in yields and CD4/CD8 profiles was detected between non-Tg littermate and CD80 Tg mice (47) . Figure 4(B) shows CD80 expression on an electronically gated CD4 -CD8subpopulation of the spleen cells. In contrast to non-Tg littermate mice, a significant level of CD80 was detected in CD80 Tg mice. The representative profiles of CD69 and CD25 on electronically gated spleen CD4 T cells are shown in Fig. 4(C) , and no significant difference in numbers of CD69 ϩ and CD25 ϩ cells was observed between normal Tglittermate and CD80 Tg mice. There was no pathological autoimmune legions in the CD80 Tg mice (data not shown).
Increased number of spleen cells, and of CD69 ϩ and CD25 ϩ CD4 T cells in MSϫCD80 double-Tg mice First, the yields of spleen cells from several MS -CD80non Tg littermates, MS ϩ CD80 -Tg and MS ϩ CD80 ϩ Tg mice of various ages were examined. All of these Tg mice had the (C3HϫFVB)F1 background. As shown in Fig. 5(A) , the cell number of spleen cells was increased~1.5-to 2-fold at all age points when CD80 Tg was constitutively expressed on B cells in MS Tg mice. The representative CD4/CD8 staining profiles of spleen cells from these Tg mice are shown in Fig.  5(B) . Although the number of spleen cells was increased in MSϫCD80 double-Tg spleen, there was no dramatic change in CD4/CD8 profiles was detected. Although, the percentages of CD4 T cells in MSϫCD80 double-Tg mice appeared to be slightly decreased, absolute cell number was not changed. In addition, no pathological legion was observed in MSϫCD80 double-Tg mice (data not shown).
Next, the activation status of MS Tg T cells in the MSϫCD80 double-Tg mice was assessed by determination of CD69 and CD25 expression. Freshly prepared spleen cells from these Tg mice were stained with anti-CD4, anti-CD8 and either one of anti-CD69 or anti-CD25 mAb. The representative profiles of CD69 and CD25 on electronically gated CD4 T cells are shown in Fig. 5(C) . The numbers of CD69 ϩ and CD25 ϩ CD4 T cells in freshly prepared spleen cells were increased Ͼ2fold in MSϫCD80 double-Tg mice. These results indicated that significantly increased numbers of MS Tg T cells were activated and expressed CD69 and CD25 when CD80 molecules were constitutively expressed on B cells. The percentages of CD69 ϩ cells in splenic B cell subpopulations were not increased in MSϫCD80 double-Tg mice (data not shown). In addition, the increase in the number of CD69 ϩ CD4 T cells was not observed in control TCR Tg DO10ϫCD80 double-Tg mice (data not shown).
The number of CD69 ϩ CD4 T cells in MSϫCD80 double-Tg mice was decreased by in vivo treatment with anti-CD80 mAb Next, the involvement of Tg CD80 molecules for the increase in the number of CD69 ϩ CD4 T cells in vivo in MSϫCD80 double-Tg mice was directly examined by in vivo treatment with anti-CD80 mAb. MSϫCD80 double-Tg mice were treated with anti-CD80 mAb i.v. and the percentages of CD69 ϩ CD4 T cells were determined on the next day. Figure 6 shows two representative staining profiles of CD69 and CD25 on electronically gated CD4 T cells of MSϫCD80 double-Tg mice with anti-CD80 mAb (1.0 mg) treatment. Although the effect on the number of CD25 ϩ cells was small, a significant effect was observed on that of CD69 ϩ cells. Three independent experiments were done and a significant blocking effect was observed in all cases. These results indicated that 
Increased efficiency in the in vitro activation of MS Tg T cells from MSϫCD80 double-Tg mice
Next, we wished to determine the effect of the constitutive expression of Tg CD80 molecules on B cells on the in vitro activation of MS Tg T cells. Spleen cells from MS Tg and MSϫCD80 double-Tg mice were cultured in vitro for 3 days in the presence or absence of anti-CD80, and then the cultured cells were stained with anti-CD4 and anti-CD69, or with anti-B220 and anti-CD80. CD69 profiles of CD4 T cells and CD80 profiles of B220 ϩ B cells are shown in Fig. 7 . In the MS single-Tg cultures, 23.1% of CD4 T cells expressed CD69. The induction of CD69 was inhibited by the addition of anti-CD80. The induction of CD69 in MSϫCD80 double-Tg cultures was significantly enhanced (23.1 versus 40.6%) and the majority of the induction was also inhibited by anti-CD80 mAb. Consistent with the enhancement of MS Tg T cell activation in MSϫCD80 double-Tg mice, the expression level of CD80 on 37°C cultured B cells was higher in MSϫCD80 double-Tg mice than that in MS single-Tg mice. These results suggested that the transgenic CD80 molecules expressed on B cells played significant roles in the MS Tg T cell activation in vitro.
IL-10 production and a preferential T h 2 cell differentiation of MS Tg T cells after in vitro cultivation at 37°C
Our results from MSϫCD80 double-Tg mice suggested that there was an inhibitory mechanism of CD80 induction on B cells in MS single-Tg mice resulting in the prevention of in vivo activation of autoreactive MS Tg T cells. We wanted to determine which molecules were involved in the down-regulation of CD80 molecules on B cells in the MS single-Tg mice. One of the well known down-regulators of CD80 expression is IL-10 (44, 45) . Consequently, we examined the ability of MS Tg T cells to produce IL-10 and their pattern of T h 1/T h 2 cell differentiation upon in vitro autostimulation. As shown in Fig.  8(A) , a significant amount of IL-10 was produced by MS Tg T cells after primary TCR-CD3 stimulations in vitro. Next, CD44 -CD4 ϩ naive T cells from MS Tg mice and control non-Tg littermate mice were co-cultured with APC of syngeneic C3H in vitro for 5 days without any exogenous antigens. Intracellular staining profiles of IFN-γ and IL-4 was assessed by the method as described in Methods. As shown in Fig.  8(B 
), a large number of IL-4-producing T h 2 cells and only a marginal number of IFN-γ-producing T h 1 cells were found to be induced in MS Tg T cell cultures. These results indicated that the MS Tg T cells were differentiated preferentially to T h 2 cells upon stimulation with auto-I-A k -bearing APC in vitro. A large amount of the T h 2-type cytokine IL-10 was produced by the in vitro induced MS Tg T h 2 cells (data not shown).
Increased serum concentration of IL-10 in MS Tg mice Next, we measured the serum IL-10 concentration of MS Tg mice and compared it with control groups. As shown in Fig.  9 , a significant increase in IL-10 concentration was detected in MS Tg mice compared with non-Tg littermate or control DO10 TCR Tg mice. These results suggested that a continuous elevation of IL-10 in the serum might down-regulate CD80 expression on B cells, resulting in a failure of MS Tg T cell activation in vivo. 
Mouse recombinant IL-10 inhibits MS Tg T cell activation in vitro
Finally, the effect of mouse recombinant IL-10 on the in vitro activation of MS Tg T cells was assessed. Graded doses of whole spleen cells from MS Tg T cells were suspension cultured in vitro in the presence of mouse recombinant IL-10. The expression level of CD69 on cultured CD4 T cells is demonstrated in Fig. 10 . Significant inhibition of CD69 expression on CD4 T cells was detected by the addition of mouse recombinant IL-10 in the culture. These results indicated that IL-10 was able to inhibit the autoreactive MS Tg T cell activation in vitro. In addition, effect of IL-10 on the induction of CD80 expression on B cells in the same cultures was assessed and a significant inhibition of CD80 expression was detected (Fig. 10, lower panels) .
Discussion
In this study, we demonstrated the involvement of CD80 (B7-1) in the regulation of naturally occurring autoreactive T cells to self MHC class II in vivo. The in vivo activation of autoreactive T cells as revealed by the increase of surface CD25 and CD69 in MSϫCD80 double-Tg mice indicated that the observed self tolerance in the MS Tg mouse was due to the down-regulation of CD80 on B cells in vivo that prevented the second signal in autoreactive T cells. In addition, IL-10mediated down-regulation of CD80 on B cells seemed to be one of the causes of this type of self tolerance.
It has been noticed that the deletion of autoreactive T cells in the thymus is not complete and some autoreactive T cells are found in peripheral circulation without apparent tissue damage (18, 19, 30, 31) . In addition, our previous study indicated that some autoreactive T cells are rather positively selected and released in peripheral circulation. They are not anergized as they can respond to autoantigen perfectly well in in vitro conditions (10) , indicating that they are only conditionally unable to respond in vivo through an inhibitory mechanism. As the frequency of such insufficient autoreactive T cells appears to be unexpectedly high under physiological conditions (16, 17) , probably the tolerance with 'clonal insufficiency' should be a common and important feature in preventing the autoreactivity of T cells. Consequently, we wished to assess the molecular mechanism governing this type of tolerance by using an autoreactive TCR Tg mouse system. As described in the previous publication (10), I-A k -reactive TCR Tg T cells were quiescent in vivo in H-2 k Tg mice, but expressed a strong autoreactivity to I-A k in vitro (10) ( Fig.  2A) . Here, we demonstrated a mechanism involved in the apparent unresponsiveness of T cells carrying the auto-I-A kreactive TCR α and β chains in Tg mice, where a co-stimulator CD80 (B7-1) was down-regulated in B cells. The activation of Tg T cells in vitro was in parallel with the appearance of CD80 molecules (Fig. 2) and was CD80 dependent (Fig. 3 ).
Constitutive expression of CD80 molecules on B cells of MS
Tg mice induced increased number of splenocytes (Fig. 5) , and resulted in the activation of Tg T cells as revealed by the increased expression of CD25 and CD69 on T cells in vivo (Fig. 5 ). This activation was inhibited by treatment with anti-CD80 in vivo (Fig. 6) .
One of the reasons for focusing on CD80 among several co-stimulators on APC is that CD80 has been known to be an inducible co-stimulator by cultivation at 37°C in vitro, which makes a clear difference in the conditions for activation between in vitro and in vivo. Considerable amounts of CD28 on T cells and CD86 on B cells are detected in vivo, whereas little expression of CD80 is observed (22) (Fig. 2B) . However, when splenocytes were cultured at 37°C in vitro, B cells started to express quite a large amount of CD80 (Fig. 2B ). This coincided with the strong autoreactivity of MS Tg T cells when they were cultured in the presence of I-A k -bearing autologous APC in vitro ( Fig. 2A) . Thus, the low expression of CD80 on MS Tg B cells in vivo can be a key factor for the maintenance of unresponsiveness in vivo by preventing appropriate co-stimulation in autoreactive MS Tg T cells. Both CD86 and I-A molecules should also be involved in the activation of MS Tg T cells in vitro (10) (Fig. 3 ), but these molecules were already expressed constitutively on B cells in vivo.
A similar mechanism for tolerance induction was reported in an experimental model of autoimmune insulitis (55) (56) (57) . In insulin-dependent diabetes mellitus (IDDM), autoreactive lymphocytes infiltrate the pancreatic islets and destroy the insulin-producing islet β cells, resulting in diabetes (58) .
Transgenic mice with overexpression of MHC class I or class II molecules on islet β cells or pancreatic acinar cells together with ectopic expression of virus antigens, or with ectopic production of IL-2 or tumor necrosis factor-α in islet β cells are known to develop IDDM (59) (60) (61) (62) . Autoimmune insulitis was, however, rarely observed in these Tg mice. Guerder et al. made double-Tg mice with CD80 and I-E expressed on islet cells, which developed autoimmune destruction of islet β cells of the pancreas (55) . A similar observation was made by Guerder et al. (56) where another double-Tg mice with ectopic expression of TNF-α and CD80 on islet β cells developed autoimmune islet destruction and diabetes. In both cases, expression of Tg CD80 on islet β cells initiated the 10 . Inhibitory effect of IL-10 on the MS Tg T cell activation in vitro. The indicated doses of whole spleen cells from MS Tg mice were suspension cultured for 3 days at 37°C in vitro. Mouse recombinant IL-10 (500 ng/ml) was added to the culture. The cultured cells were stained with anti-CD69 and anti-CD4, or with anti-CD80 and anti-B220. Staining profiles of CD69 on electronically gated CD4 T cells and CD80 on electronically gated B220 ϩ B cells are depicted. The percentages of CD69 ϩ cells or CD80 ϩ cells are indicated in each panel. FCM analysis was done with PI for dead cell exclusion. stimulation of autoreactive T cells resulting in autoimmune insulitis. Harlan et al. established triple-Tg mice in which co-expression of a viral glycoprotein (GP of lymphocytic choriomeningitis virus) and transgenic CD80 on islet β cells was achieved in the presence of circulating T cells with a Tg TCR specific for the GP peptide (57) . All three transgenes appeared to be required for the development of diabetes with autoimmune insulitis. Thus, the expression of co-stimulator CD80 on target cells was found to be essential for the initiation of autoimmune insulitis.
Although CD86 is also a co-stimulator of CD28, ectopic expression of CD86 on islet cells did not induce autoimmune insulitis. In addition, recent studies in NOD mice suggested that the initiation of immune responses, especially following initial antigen exposure, was regulated by CD80 rather than CD86 (22, 36) . In MS Tg spleen, a considerable amount of CD28 was expressed on T cells and CD86 was on B cells, while no T cell activation was observed. Taken together, the expression of CD80 appeared to be more critical for the initiation of the activation of 'insufficient T cells'. There should be some differential roles of CD80 molecules from CD86 molecules (22) .
In our MSϫCD80 double-Tg experimental system, the constitutive expression of a co-stimulator CD80 on B cells induced the activation of autoreactive Tg T cells in vivo. However, no pathological autoimmune legions were detected, indicating that there were other factors preventing the autoimmune legions in vivo. The substitution of only the CD80/CD28 signaling pathway was not sufficient for the break of the observed tolerance. Indeed, we were able to detect a significant increase in the number of activated MS Tg T cells in the spleen of MSϫCD80 double-Tg mice, yet the majority of MS Tg T cells were not activated even though almost all B cells express considerable amounts of CD80 molecules (Fig.  5 ). Another controlling factor for the activation of MS Tg T cells might be the expression level of I-A k on B cells (ligand of the autoreactive MS TCR). It was reported that the high expression level of MHC molecules was critical for the initiation of autoreactive responses against pancreatic islet cells (55, 63, 64) . In parallel with MS Tg T cell activation in vitro, increased expression of I-A k on splenic B cells was detected (Fig. 2B ). However, in contrast to pancreatic islet cells, considerable amounts of I-A k molecules were already constitutively expressed on B cells in vivo. Thus, the involvement of I-A k for the unresponsiveness of MS Tg T cells in vivo appeared to be unlikely. IL-10 was originally described as a cytokine synthesis inhibitory factor (reviewed in 65). IL-10 was found to act on APC and inhibited their T cell stimulating activity by downregulating MHC class II and co-stimulator molecules CD80 and CD86 on APC (66, 67) . MS Tg T cells were able to produce a large amount of IL-10 after primary TCR-CD3 stimulation in vitro (Fig. 8A) . Interestingly, MS Tg TCR were derived from a IL-10-producing T h 2 cell clone and after secondary stimulation in vitro the majority of Tg T cells were differentiated to T h 2 cells (Fig. 8B ). In addition, the serum concentration of IL-10 was found to be increased in MS Tg mice ( Fig. 9 ) and the activation of MS Tg T cells after cultivation in vitro was significantly inhibited by the addition of recombinant mouse IL-10 in the culture (Fig. 10) . Thus, although the real source of the increased serum level of IL-10 in MS Tg mice remains clear, the activation of MS Tg T cells may be suppressed in vivo by the continuous presence of IL-10.
Although the concentration of IL-10 in the MS Tg serum was significantly increased, its level was as much as twice normal concentrations (~100 pg/ml) ( Fig. 9 ). On the other hand, Ͼ100 ng/ml of rIL-10 was required for the inhibition of the MS Tg T cell activation in vitro (Fig. 10) . It is possible that the local IL-10 concentration in the spleen where MS Tg T cells interact with MHC class II-bearing APC is much higher than that detected in the serum. It is very likely that CD80 expression is controlled by other unknown mechanisms as well.
In summary, we have demonstrated the involvement of CD80 expression on B cells in tolerance induction for naturally existing auto-MHC class II-reactive T cells. In addition, the involvement of IL-10-mediated regulation of self tolerance was suggested.
